Renee Williams, MD, MHPE

Explore evolving colorectal cancer screening, from colonoscopy to advanced DNA/RNA stool tests, plus risk-based strategies and shared decisions that boost early detection.

Positive FIT/Cologuard? See why follow-up colonoscopy is often $0 and how navigation, rides, and time-off support boost screening.

Positive stool test? Learn why follow-up colonoscopy is often covered and how clinics tackle cost, time-off, and transport barriers.

See how FIT cutoffs change accuracy, why Cologuard raises sensitivity

Learn how FIT, Cologuard, blood tests and colonoscopy compare on accuracy, follow-up timing, and easier prep options for screening.

Clinicians share practical tips to boost colorectal screening, comparing colonoscopy and stool tests while addressing fears.

Doctors share tactics to boost colorectal screening: compare colonoscopy vs stool tests, address fears, and prevent cancer before symptoms.

The expert faculty explore how clinicians approach rectal bleeding and surveillance decisions in colorectal cancer screening.

In this episode titled, ‘Shifting Epidemiology and Risk Factors in Colorectal Cancer,’ the moderator introduces the evolving landscape of colorectal cancer screening and highlights the growing importance of early detection.

Williams explains colorectal cancer screening options, persistent barriers to uptake, and strategies to improve screening rates.